Serological and participatory epidemiological study of Camelpox and field evaluation of vaccine in gabi rasu zone, Afar region, ethiopia
No Thumbnail Available
Date
2015-06
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababauniversity
Abstract
Camelpox virus (CMLV) causes a smallpox-like illness in a unique host, the camel.
Although the disease is enzootic in almost all regions where camel husbandry is
practiced, and is responsible for severe economic losses, its epidemiology has not
extensively investigated. Thus, sero- and participatory- epidemiological investigation of
the disease was carried out in Gabi Rasu zone using cross sectional study design to
determine its seroprevalence and associated risk factors as well as using seasonal
calendar to identify its seasonal occurrences. In addition camelpox vaccine, the only
available vaccine for the species of animal in Ethiopia, was evaluated under field
condition by seroconversion using the before and after with control experimental study
design. The study was conducted in two selected districts of Gabi Rasu zone, from
November 2014 to May 2015.
Out of 384 camel sera samples tested by virus neutralization test, 74 were seropositive
for camelpox, giving an overall seroprevalence of 19.3% (95% CI= 15.3-23.2%) in the
study area. A seroprevalence of 21.6 (95% CI= 16.0-27.2) and 16.7 (95% CI=11.2-22.1)
were recorded in Amibara and Awash Fentale districts, respectively. At least one
seropositive camel was detected from 25 herds among 30 examined giving 83.3% (95%
CI = 70.0-96.6) herd level prevalence. Univariable and multivariable logistic regression
analysis of the assumed risk factors showed that age of the camel was the only risk factor
associated with the occurrence of serpositivity to camelpox. The results indicated that
camelpox seroprevalence was significantly higher in adult (24.4%, 95% CI= 18.4-30.4)
than young age group (13.9%, 95% CI= 8.9-18.8) with a 2 fold greater odds of
occurrence. The small-scale vaccine evaluation trial indicated that, vaccination of
camels with the live attenuated camelpox vaccine resulted in a significantly higher
seroconvesrion rate compared to unvaccinated camels. However, among 58 vaccinated
camels with pre-vaccination seronegative results, 32 found seropositive at postvaccination
serum analysis using VNT, indicating low (55.2%) seroconversion rate.
Various explanations have suggested for the failure of post vaccination seroconversion
on 44.8% vaccinated camels. Interview of pastoralists has revealed that camelpox is one
x
of the most common camel diseases in the area. The disease was reported commonly to
occur during the minor (Sugum) and major (Kerma) rainy seasons by informant groups.
In conclusion camelpox seems to be endemic in Gabi Rasu zone with seasonal
occurrence during rainy season. Therefore, considering the economical significance of
the disease, vaccination of young camels along side training of pastoralists for improved
management strategies could have a significant importance in diminishing the virus from
circulation. However, further extensive studies that lead to conclusive results on the
efficacy of the vaccine under evaluation are recommended.
Key words: Afar, Camelpox, Participatory Epidemiology, Risk Factors, Seroprevalence,
VNT
Description
Keywords
Afar, Camelpox, Participatory Epidemiology, Risk Factors, SeroprevalenceVNT